Pediatric Neurology Briefs (Dec 1997)
Sumatriptan Nasal Spray for Acute Migraine
Abstract
The efficacy and side effects of intranasal sumatriptan (20 mg, 10 mg) or placebo in the treatment of a single migraine attack were evaluated in two randomized, double-blind, multicenter studies of 409 and 436 adult patients, funded by Glaxo Wellcome.
Keywords
